Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
出版年份 2021 全文链接
标题
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
作者
关键词
Immunization, COVID-19, Adenoviral associated, Inflammatory bowel disease, Rheumatoid arthritis, Vasculitis, Spondyloarthropathy, Systemic lupus erythematosus
出版物
AUTOIMMUNITY REVIEWS
Volume -, Issue -, Pages 102927
出版商
Elsevier BV
发表日期
2021-08-30
DOI
10.1016/j.autrev.2021.102927
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID‐19 vaccination and psoriatic patients under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers
- (2021) G. Damiani et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
- (2021) A. Al‐Janabi et al. BRITISH JOURNAL OF DERMATOLOGY
- COVID‐19 vaccine does not trigger psoriasis flares in psoriatic patients treated with apremilast
- (2021) A. Pacifico et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies
- (2021) Serre-Yu Wong et al. GASTROENTEROLOGY
- Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series
- (2021) Victoria Furer et al. RHEUMATOLOGY
- Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
- (2021) Abdulla Watad et al. Vaccines
- SARS-COV-2 vaccination after stem cell transplantation for scleroderma
- (2021) Doron Rimar et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Giuseppe A Ramirez et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response’
- (2021) Timm H Westhoff et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Jesse Veenstra et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY
- (2021) V. Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Chiara Salviani et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
- (2021) Serena Bugatti et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Larissa Valor-Méndez et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Vaccinations in patients with inflammatory bowel disease
- (2021) Fabio Salvatore Macaluso et al. DIGESTIVE AND LIVER DISEASE
- Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
- (2021) Nabeel Khan et al. GASTROENTEROLOGY
- Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
- (2021) Emire Seyahi et al. RHEUMATOLOGY INTERNATIONAL
- Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
- (2021) Andrea Rubbert-Roth et al. Lancet Rheumatology
- Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
- (2021) Michael D. Kappelman et al. GASTROENTEROLOGY
- Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- (2020) Federica Raucci et al. AUTOIMMUNITY REVIEWS
- Covid-19 and autoimmunity
- (2020) Michael Ehrenfeld et al. AUTOIMMUNITY REVIEWS
- Effect of IBD medications on COVID-19 outcomes: results from an international registry
- (2020) Ryan C Ungaro et al. GUT
- COVID-19 and autoimmune diseases
- (2020) Yu Liu et al. CURRENT OPINION IN RHEUMATOLOGY
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
- (2020) Anupam Kumar Singh et al. United European Gastroenterology Journal
- Vaccinations in patients with immune-mediated inflammatory diseases
- (2010) J.-F. Rahier et al. RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now